Sevoflurane in paediatric anaesthesia.
Sevoflurane is a potent inhalational agent, combining several advantages of specific interest in paediatric anaesthesia. Rapid and smooth induction, a safe cardiovascular profile, rapid emergence and a short postoperative recovery with minimal side effects are ideal characteristics of this agent for the use in paediatric anaesthesiology. The apparent improvement in management should not obscure the fact that sevoflurane in higher MAC should be used with caution in renal impairment. For the future world of our children, the lack of chlorine in the structure makes sevoflurane theoretically less ozone-depleting than halothane and isoflurane, a substance contributing to environmental protection.
Müller
C M
CM
Department of Anaesthesiology and General Intensive Care, University of Vienna, Austria.
Krenn
C G
CG
Urak
G
G
Zimpfer
M
M
Semsroth
M
M
D000393:Air Pollutants / Q000737:chemistry; D000762:Anesthesia Recovery Period; D000769:Anesthesia, Inhalation; D018685:Anesthetics, Inhalation / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry; D002648:Child; D004987:Ethers / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry; D006221:Halothane / Q000737:chemistry; D006321:Heart / Q000187:drug effects; D006801:Humans; D007223:Infant; D007530:Isoflurane / Q000737:chemistry; D007668:Kidney / Q000187:drug effects; D008738:Methyl Ethers; D010126:Ozone / Q000737:chemistry; D012449:Safety; D000077149:Sevoflurane
D000393:Air Pollutants; D018685:Anesthetics, Inhalation; D004987:Ethers; D008738:Methyl Ethers; D000077149:Sevoflurane; D010126:Ozone; D007530:Isoflurane; D006221:Halothane